MARKET

AMPE

AMPE

Ampio Pharma
AMEX
0.6200
-0.0919
-12.92%
After Hours: 0.6200 0 0.00% 17:14 04/12 EDT
OPEN
0.6766
PREV CLOSE
0.7119
HIGH
0.6990
LOW
0.6200
VOLUME
52.78K
TURNOVER
0
52 WEEK HIGH
8.30
52 WEEK LOW
0.6200
MARKET CAP
703.92K
P/E (TTM)
-0.0582
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AMPE last week (0401-0405)?
Weekly Report · 5d ago
AMPIO PHARMACEUTICALS RECEIVED AUDIT OPINION WITH GOING CONCERN EXPLANATION
Reuters · 04/03 18:33
Weekly Report: what happened at AMPE last week (0325-0329)?
Weekly Report · 04/01 10:43
Ampio Pharmaceuticals Q4 EPS $(2.48) Up From $(3.60) YoY
Benzinga · 03/28 03:46
AMPE Stock Earnings: Ampio Pharmaceuticals Reported Results for Q4 2023
Ampio Pharmaceuticals reported earnings per share of -$2.48 for the first quarter. The company did not report any revenue for the quarter. Ampo Pharmaceuticals is not listed as a company in the S&P 500 index of large companies on Tuesday.
Investorplace · 03/28 02:53
GOEV, NBSE and FLGC among pre-market losers
GOEV, NBSE and FLGC among pre-market losers. NeuBase Therapeutics (NBSE) -58%. AppTech Payments Corp (APCX) announces proposed underwritten public offering. Bluebird bio (BLUE) reports Q4 results.
Seeking Alpha · 03/26 12:15
Ampio Shares Fall 22% as Co. Plans to Voluntarily Delist From NYSE American
Ampio Pharmaceuticals plans to voluntarily delist shares from the NYSE American Exchange. The company's stock hit a 52-week low of $1.50 on March 7. Ampio says it plans to suspend its reporting obligations under the Securities and Exchange Act of 1934. The delisting is expected to become effective April 14.
Dow Jones · 03/25 21:39
Ampio Reports Voluntary Delisting And SEC Deregistration
Benzinga · 03/25 21:13
More
About AMPE
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Webull offers Ampio Pharmaceuticals Inc stock information, including AMEX: AMPE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMPE stock methods without spending real money on the virtual paper trading platform.